Type 2 Cytokine Serum Levels in Healthy Sickle Cell Disease Patients

Journal of the National Medical Association

Volumn 89, Issue 11, 1997, Pages 753-757

  Taylor, Stephen C ^a   Shacks, Samuel J ^a   Qu, Zengwei ^a   Wiley, Paul ^a  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

Cytokines; Sickle cell disease

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6;

ADOLESCENT; ARTICLE; BIOSYNTHESIS; BLOOD; CHILD; CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; PRESCHOOL CHILD; PROGNOSIS; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; SICKLE CELL ANEMIA;

ADOLESCENT; ANEMIA, SICKLE CELL; CHILD; CHILD, PRESCHOOL; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTERLEUKIN-10; INTERLEUKIN-4; INTERLEUKIN-6; PROGNOSIS; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY;

EID: 0031263208     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Pauling L, Itano HA, Singer SJ, Wells IC. Sickle cell anemia, a molecular disease. Science. 1949;110:543-548.
2. Neel JV. The inheritance of sickle cell anemia. Science. 1949;110:64-66.
3. Ingram VM. A specific difference between the globins of normal human and sickle cell anemia hemoglobins. Nature. 1956;178:792-794.
4. Shelton JR, Schroeder WA. Further N-terminal sequences in human hemoglobins A, S, and F by Edman's phenylhydantoin method. Journal of the American Chemical Society. 1960;82:3342-3345.
5. Ranney HM. Observations on the inheritance of sickle cell hemoglobin and hemoglobin C. J Clin Invest. 1954;33:1634-1641.
6. Smith JA. The natural history of sickle cell disease. Ann NY Acad Sci. 1989;565:104-108.
7. Pearson HA. The kidney, hepatobiliary system and spleen in sickle cell anemia. Ann NY Acad Sci. 1989;565:120-125.
8. Ranney HM. The spectrum of sickle cell disease. Hosp Pract. 1992;28:133-163.
9. Ballas SK. Management of sickle cell disease. Hospital Physician. 1993;29:12-15, 29-35.
10. Brown AK, Miller ST, Agatisa P. Care of infants with sickle cell disease. Pediatrics. 1989;83:897-900.
11. Leikin SL, Gallagher D, Kinney TR, Sloane D, Klug P, Rida W. Mortality in children with sickle cell disease. Pediatrics. 1989;84:500-508.
12. Platt OS, Brambilla DJ, Roose WF, Milner PF, Castro O, Steinberg MH, et al. Mortality in sickle cell disease: Life expectancy and risk factors for early death. N Engl J Med. 1994;330:1639-1644.
13. Solanki DL, Berdoff RL. Severe Mycoplasma pneumonia with pleural effusions in a patient with sickle hemoglobin C (SC) disease: case report and review of the literature. Am J Med. 1979;66:707-710.
14. Cole TB, Smith SJ, Buchanan GR. Hematologic alterations during acute infection in children with sickle cell disease. Pediatr Infect Dis J. 1987;6:454-457.
15. Bakshi SS, Grover R, Cabezon E, Wethers DL. Febrile episodes in children with sickle cell disease treated on an ambulatory basis. J Assoc Acad Minor Phys. 1991;2:80-83.
16. Krachman SL, Lodato RF, D'Alonzo GE. Managing acute chest syndrome in sickle cell patients. Journal of Critical Illness. 1994;9:375-392.
17. Wong WY, Powars DR, Overturf GD. Infections in children with sickle cell anemia. Infections in Medicine. 1995;12:331-338.
18. Pearson HA, Gallagher D, Chilcote R, Sullivan E, Wilmas J, Espeland M, et al. Developmental pattern of splenic dysfunction in sickle cell disorders. Pediatrics. 1985;76:392-397.
19. Corry JM, Polhill RB, Edmonds SR, Johnston RB. Activity of the alternative complement pathway after splenectomy; comparison to activity in sickle cell disease and hypogammaglobulinemia. J Pediatr. 1979;95:963-969.
20. 2 deficiency in sickle cell anemia. Scandinavian Journal of Haematology. 1984;33:129-134.
21. Boghossian SH, Wright G, Webster AD, Segal AW. Investigations of host defense in patients with sickle cell disease. Br J Haematol. 1985;59:523-531.
22. Wang W, Herron H, Presbury G, Williams J. Lymphocyte phenotype and function in chronically transfused children with sickle cell disease. Am J Hematol. 1985;20:31-40.
23. Daeschner CW, Carpentieri V, Goldman AS, Haggard ME. Zinc deficiency and blood lymphocyte function with sickle cell disease. Scandinavian Journal of Haematology. 1985;35:185-190.
24. Sandhadj K, Chout R, Gessain A, Sasco AJ, Yoyo M, Mezard F, et al. Cell-mediated immunity in patients with sickle cell anemia. Thymus. 1988;12:203-213.
25. Cetiner S, Akoglu TF, Kilinc Y, Akoglu E, Kumi M. Immunological studies in sickle cell disease: Comparison of homozygote mild and severe variants. Clin Immunol Immunopathol. 1989;53:32-39.
26. Abdullah JM, Kukuruga M, Nakeff A, Prasad AS. Cell cycle distribution defect in PHA-stimulated T lymphocytes of sickle cell disease patients. Am J Hematol 1988;28:279-281.
27. Ballester OF, Abdullah JM, Prasad AS. Lymphocyte subpopulation abnormalities in sickle cell anemia: a distinctive pattern from that of AIDS. Am J Hematol. 1986;21:23-27.
28. Taylor SC, Shacks SJ, Highshaw RA, Franco R, Baura G. Immunologic dysfunctions in sickle cell disease versus AIDS. Pediatr Res. 1988;23(part 2):384A.
29. Taylor SC, Shacks SJ, Villicana SM, Dinkins G, Olivares J. Interferon production in sickle cell disease. Lymphokine Research. 1990;9:415-423.
30. Taylor S, Shacks S, Villicana S, Dinkins G, Olivares J. Lymphocyte blastogenic responses in sickle cell disease. Immunol Invest. 1991;20:645-655.
31. Taylor SC, Shacks SJ, Mitchell RA. Mononuclear cell profiles in sickle cell disease. J Invest Med. 1995;43(suppl 1):185A.
32. Shearer G. Type 1 helper T-cell response: a leader in HIV control. Clinical Immunology Spectrum. 1994;6:1-12.
33. Moore CM, Ehlayel M, Leiva LE, Sorensen RU. New concepts in the immunology of sickle cell disease. Ann Allergy Asthma Immunol. 1996;76:385-403.
34. Reiser H, Stadecker MJ. Costimulatory B7 molecules in the pathogenesis of infectious and autoimmune diseases. N Engl J Med. 1996; 335:1369-1377.
35. Baiter M. Cytokines move from the margins into the spotlight. Science. 1995;268:205.
36. Rautonen N, Martin NL, Rautonen J, Rooks Y, Mentzer WC, Wara DW. Low number of antibody producing cells in patients with sickle cell anemia. Immunol Lett. 1992;34:207-212.
37. Malave I, Escalona E, Perdomo Y, Pocino M, Malave D, Arends T. In vitro antibody synthesis by peripheral blood mononuclear cells from patients with sickle cell disease. Acta Haematol. 1990;84:89-94.
38. Borish L, Rosenwasser LJ. Update on cytokines. J Allergy Clin Immunol. 1996;97:19-34.
39. Masood R, Lunardi-Iskandar Y, Moudgil T, Law RE, Huang C, Puri RK, et al. IL-10 inhibits HIV-1 replication and is induced by tat. Biochem Biophys Res Commun. 1994;202:374-383.
40. Taylor SC, Shacks SJ, Mitchell RA. In vitro lymphocyte blastogenic responses and cytokine production in sickle cell disease patients with acute pneumonia. Pediatr Infect Dis J. 1996;15:340-344.
41. Taylor S, Shacks SJ. Lymphokine and NK cell activity in sickle cell disease. Pediatric Asthma, Allergy and Immunology. 1989;3:217-225.